<qa>  What is the main purpose of this prospective study?The main purpose of this prospective study is to demonstrate the therapeutic equivalence of topical brinzolamide dosed three times daily compared with AzoptTM brinzolamide ophthalmic suspension 1 dosed three times daily in IOP reduction in patients with POAG or OH. 